CLINICAL_TRIALS
trial_result
· 2010-07-23
Clinical Trial Update: MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029) [Phase 3]
Summary
Phase 3 trial comparing MK0462 5 mg, Sumatriptan 50 mg, and placebo for migraine headache has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Migraine Headache | Phase 3 | Status: COMPLETED | Results posted: 2010-07-23